Casi Deyoung

Casi joined Shattuck in December of 2019. She brings a background in management consulting and over twenty years in the healthcare and life science industries. She has held leadership roles in five US start-up businesses (private and public). Most recently Casi served as Chief Operating Officer for ImmuneSensor Therapeutics where she was responsible for corporate strategy, start-up operations, intellectual property, oversight of the company’s first IND filing and the initiation of a first-in-human Phase 1 clinical trial. Previously, she held leadership positions including Chief Business Officer at Mirna Therapeutics, Vice President of Business Development at Reata Pharmaceuticals, Vice President of Business Development at ODC Therapy and Operations Director for Oncology at EMD Pharmaceuticals and Merck KGaA. Casi earned a B.S. in Chemistry, from Southwestern University and an M.B.A. from the McCombs School of Business at the University of Texas at Austin.